Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability

被引:796
作者
Stewart, WF
Lipton, RB
Dowson, AJ
Sawyer, J
机构
[1] Innovat Med Res Inc, Stamford, CT 06905 USA
[2] Johns Hopkins Univ, Sch Publ Hlth, Baltimore, MD USA
[3] Innovat Med Res Inc, Hunt Valley, MD USA
[4] Albert Einstein Coll Med, Bronx, NY 10467 USA
[5] Kings Coll London Hosp, Kings Headache Serv, London, England
关键词
D O I
10.1212/WNL.56.suppl_1.S20
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The MIDAS Questionnaire was developed to assess headache-related disability with the aim of improving migraine care. Headache sufferers answer five questions, scoring the number of days, in the past 3 months, of activity limitations due to migraine. The internal consistency, test-retest reliability, and validity (accuracy) of the questionnaire were assessed in separate population-based studies of migraine sufferers. In addition, the face validity, ease of use, and clinical utility of the questionnaire were evaluated in a group of 49 physicians who independently rated disease severity and need for care in a diverse sample of migraine case histories. The test-retest Pearson correlation coefficient for the total MIDAS score was approximately 0.8. The MIDAS score was valid when compared with a reference diary-based measure of disability; the overall correlation between MIDAS and the diary-based measure was 0.63. The MIDAS score was also correlated with physicians' assessments of need for medical care (r = 0.69). From studies completed to date, the MIDAS Questionnaire has been shown to be internally consistent, highly reliable, valid, and correlates with physicians' clinical-judgment. These features support its suitability for use in clinical practice. Use of the MIDAS Questionnaire may improve physician-patient communication about headache-related disability and may favorably influence health-care delivery for migraine patients.
引用
收藏
页码:S20 / S28
页数:9
相关论文
共 31 条
  • [1] BABIAK LM, 1994, QUAL LIFE RES, V3, P58
  • [2] ASSESSMENT OF HEALTH-RELATED QUALITY-OF-LIFE IN MIGRAINE
    DAHLOF, C
    [J]. CEPHALALGIA, 1993, 13 (04) : 233 - 237
  • [3] DELISSOVOY G, 1994, NEUROLOGY, V44, P56
  • [4] THE HENRY-FORD-HOSPITAL HEADACHE-DISABILITY-INVENTORY (HDI)
    JACOBSON, GP
    RAMADAN, NM
    AGGARWAL, SK
    NEWMAN, CW
    [J]. NEUROLOGY, 1994, 44 (05) : 837 - 842
  • [5] Janca A, 1997, J NEUROL SCI, V145, P1
  • [6] LIPTON RB, 1994, NEUROLOGY, V44, P63
  • [7] Lipton RB, 1999, CEPHALALGIA, V19, P337
  • [8] Lipton RB, 2000, REV CONTEMP PHARMACO, V11, P63
  • [9] LIPTON RB, 2000, HEADACHE, V40, P417
  • [10] LIPTON RB, CLIN UTILITY NEW INS